Empirical Finance, LLC Amgen Inc Transaction History

Empirical Finance, LLC

  • $1.7 Billion
  • Q3 2024

A detailed history of Empirical Finance, LLC transactions in Amgen Inc stock. As of the latest transaction made, Empirical Finance, LLC holds 18,754 shares of AMGN stock, worth $4.94 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares
18,754
Previous 18,374 2.07%
Holding current value
$4.94 Million
Previous $5.74 Million 5.26%
% of portfolio
0.36%
Previous 0.36%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024
BUY
$309.38 - $337.38 $117,564 - $128,204
380 Added 2.07%
18,754 $6.04 Million
Q2 2024

Jul 30, 2024
SELL
$262.75 - $319.31 $367,587 - $446,714
-1,399 Reduced 7.08%
18,374 $5.74 Million
Q1 2024

May 06, 2024
BUY
$268.87 - $324.56 $190,359 - $229,788
708 Added 3.71%
19,773 $5.62 Million
Q3 2023

Nov 02, 2023
BUY
$218.65 - $271.46 $337,158 - $418,591
1,542 Added 8.8%
19,065 $5.12 Million
Q2 2023

Jul 27, 2023
BUY
$214.27 - $253.37 $421,040 - $497,872
1,965 Added 12.63%
17,523 $3.89 Million
Q1 2023

Apr 05, 2023
BUY
$225.79 - $275.2 $153,537 - $187,136
680 Added 4.57%
15,558 $3.76 Million
Q4 2022

Jan 24, 2023
BUY
$229.03 - $291.01 $238,420 - $302,941
1,041 Added 7.52%
14,878 $3.91 Million
Q3 2022

Nov 04, 2022
BUY
$224.46 - $253.15 $466,203 - $525,792
2,077 Added 17.66%
13,837 $3.12 Million
Q2 2022

Aug 01, 2022
BUY
$230.71 - $256.74 $138,656 - $154,300
601 Added 5.39%
11,760 $2.86 Million
Q1 2022

Apr 21, 2022
BUY
$219.27 - $242.57 $255,230 - $282,351
1,164 Added 11.65%
11,159 $2.7 Million
Q4 2021

Feb 04, 2022
BUY
$198.88 - $227.6 $510,524 - $584,249
2,567 Added 34.56%
9,995 $2.25 Million
Q3 2021

Nov 12, 2021
BUY
$212.27 - $248.7 $85,332 - $99,977
402 Added 5.72%
7,428 $1.58 Million
Q2 2021

Aug 10, 2021
BUY
$233.58 - $259.14 $210,689 - $233,744
902 Added 14.73%
7,026 $1.71 Million
Q4 2020

Feb 02, 2021
BUY
$216.38 - $257.67 $218,111 - $259,731
1,008 Added 19.7%
6,124 $1.41 Million
Q3 2020

Oct 28, 2020
BUY
$234.65 - $260.95 $829,018 - $921,936
3,533 Added 223.18%
5,116 $1.3 Million
Q3 2020

Oct 26, 2020
SELL
$234.65 - $260.95 $595,776 - $662,552
-2,539 Reduced 61.6%
1,583 $306,000
Q2 2020

Jul 20, 2020
BUY
$197.81 - $242.74 $815,372 - $1 Million
4,122 New
4,122 $972,000
Q2 2020

Jul 20, 2020
SELL
$197.81 - $242.74 $719,039 - $882,359
-3,635 Closed
0 $0
Q1 2020

Apr 16, 2020
BUY
$182.24 - $241.7 $224,337 - $297,532
1,231 Added 51.21%
3,635 $737,000
Q4 2019

Jan 27, 2020
BUY
$189.21 - $243.2 $155,341 - $199,667
821 Added 51.86%
2,404 $580,000
Q3 2019

Oct 30, 2019
BUY
$174.11 - $208.62 $4,178 - $5,006
24 Added 1.54%
1,583 $306,000
Q2 2019

Jul 09, 2019
SELL
$166.7 - $195.41 $5,334 - $6,253
-32 Reduced 2.01%
1,559 $287,000
Q1 2019

May 10, 2019
SELL
$180.87 - $203.88 $1.28 Million - $1.44 Million
-7,087 Reduced 81.67%
1,591 $302,000
Q4 2018

Jan 22, 2019
SELL
$178.4 - $208.25 $23,548 - $27,489
-132 Reduced 1.5%
8,678 $1.69 Million
Q3 2018

Oct 18, 2018
SELL
$185.29 - $208.89 $1.2 Million - $1.35 Million
-6,454 Reduced 42.28%
8,810 $1.83 Million
Q2 2018

Jul 09, 2018
BUY
$166.05 - $186.51 $2.27 Million - $2.55 Million
13,673 Added 859.4%
15,264 $2.82 Million
Q1 2018

May 10, 2019
SELL
$169.43 - $198.0 $2.97 Million - $3.47 Million
-17,514 Reduced 91.67%
1,591 $302,000
Q1 2018

Apr 25, 2018
BUY
$169.43 - $198.0 $2.12 Million - $2.48 Million
12,500 Added 189.25%
19,105 $3.26 Million
Q4 2017

Feb 01, 2018
BUY
$168.79 - $188.59 $1.11 Million - $1.25 Million
6,605
6,605 $1.15 Million

Others Institutions Holding AMGN

# of Institutions
3,125
Shares Held
409M
Call Options Held
7.56M
Put Options Held
7.2M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Empirical Finance, LLC Portfolio

Follow Empirical Finance, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Empirical Finance, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Empirical Finance, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email